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Dietary (−)-epicatechin affects NF-κB activation
and NADPH oxidases in the kidney cortex of
high-fructose-fed rats
Paula Denise Prince, a,b Cecilia Rodríguez Lanzi,c,d César G. Fraga †a,b and
Mónica Galleano *†a,b
Inflammation involves the activation of redox-sensitive transcrip-
tion factors, e.g., nuclear factor κB (NF-κB). Administration of
(−)-epicatechin to high-fructose-fed rats prevented NF-κB acti-
vation and up-regulation of the NADPH oxidase 4 (NOX4) in the
kidney cortex. These results add mechanistic insights into the
action of (−)-epicatechin diminishing inflammatory responses.
Introduction
A chronic low-grade inflammatory state is associated with a wide
range of chronic conditions such as metabolic syndrome, non-
alcoholic fatty liver disease, type 2 diabetes mellitus and cardio-
vascular disease. The inflammatory process is initiated by the
up-regulation of genes encoding for diverse mediators, such as
cytokines and chemokines, through the activation of different
transcription factors including nuclear factor κB (NF-κB).1
NF-κB can be activated by different additional and intra-
cellular stimuli.2 NF-κB is a heterodimer composed of
members of the Rel/NF-κB family of proteins (e.g., p50 and
p65) and resides in the cytosol in an inactive form bound to
the inhibitory protein κBα (IκBα). During NF-κB activation,
IκBα kinases (IKKα/β) phosphorylate IκBα leading to its sub-
sequent ubiquitination and degradation by the proteasome.
The released NF-κB is susceptible to phosphorylation in p65
which allows the translocation to the nucleus, where it binds
to κB sites in DNA and regulates the transcription of proin-
flammatory mediators such as interleukin 6, TNFα, and indu-
cible nitric oxide synthase (iNOS).3 The role of toll-like recep-
tors (TLR) in NF-κB activation is well characterized.
Mammalian TLRs are sensors of pathogen-associated mole-
cules such as bacterial lipopolysaccharides, lipopeptides and
flagellins as well as of endogenous ligands such as diverse
damage-associated molecules. TLR-4 recognizes lipopolysac-
charides from Gram-negative bacteria and endogenous mole-
cules such as heat shock protein 60, fibronectin and fibrino-
gen, leading to the activation of the NF-κB signalling pathway.2
The family of NADPH oxidases (NOX) consists of several
superoxide anion- or H2O2-producing enzymes. In the rat kidney,
NOX1, NOX2 and NOX4 are expressed in mesangial cells, vascu-
lar smooth muscle cells, endothelial cells, podocytes, tubular epi-
thelial cells and interstitial fibroblasts. NOX2 consists of a mem-
brane-bound catalytic subunit (gp91phox) and regulatory/activat-
ing cytosolic subunits, e.g., p47phox and p67phox.4 The isoform
NOX1 has a membrane-bound catalytic subunit with the same
name (NOX1) and specific cytosolic regulatory/activating sub-
units, e.g., NOX1 organizer (NOXO1). Electrons from NADPH are
transferred to molecular oxygen, generating the superoxide anion
as a product of NOX1 and NOX2 activity. NOX4 activation does
not require the recruitment of cytosolic subunits and generates
H2O2 rather than the superoxide anion.
5
Flavanol (−)-epicatechin, which is present in many plants
consumed by humans, has been proposed as a modulator of
NOX-dependent oxidant production in vivo in many tissues
subjected to stress conditions.6,7 The mechanisms behind
such effects imply the inhibition of the overexpression of
different NOX subunits.8–16 Moreover, in vivo anti-inflamma-
tory effects have been reported for (−)-epicatechin through
downregulation of the NF-κB activation pathway in
fructose overload and other stress models.8,11,14–16 In this
study, high fructose feeding triggered NF-κB activation in the
renal cortex of rats. This was associated with increase in
NOXO1 and NOX4 expression levels without changes in TLR-4
expression. Dietary (−)-epicatechin could prevent NF-κB acti-
vation at multiple steps in association with a decrease in
NOX4 expression.†These authors share senior authorship.
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Materials and methods
Materials
Primary antibodies for TLR-4 (#30002), NOX4 (#21860) and
β-actin (#47778) and secondary antibodies rabbit anti-goat
IgG-HRP (#2768), mouse anti-rabbit IgG-HRP (#2357), and goat
anti-mouse IgG-HRP (#2005) were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). The primary and second-
ary antibodies for IκB kinase α (IKKα) (#11930), p-IKKα/β
(Ser176/180) (#2697), inhibitor of κBα (IκBα) (#4814), p-IκBα
(Ser32) (#2859), NF-κB p65 (#8242) and p-NF-κB p65 (Ser536)
(#3033) were obtained from Cell Signaling Technology (Boston,
MA, USA). Primary antibodies for NOX1 (ab46545) and NOXO1
(ab131205) were purchased from Abcam Inc. (Cambridge, MA,
USA). (−)-Epicatechin was obtained from Sigma Chemical Co.
(St Louis, MO, USA), and fructose (purity ≥99.5%) was
obtained from Droguería Saporiti (Buenos Aires, Argentina).
Commercial rat chow was purchased from Gepsa-Feeds
(Buenos Aires, Argentina).
Animals, diets and experimental design
All procedures were in agreement with the standards for the
care of laboratory animals outlined in the National Institutes
of Health Guide for Care and Use of Laboratory Animals (NIH
Pub. No. 85-23, revised 1996) and were approved by the
Secretary of Science and Technology of the School of Medicine,
National University of Cuyo. Male Sprague Dawley rats were
housed under the conditions of controlled temperature
(21–25 °C) and humidity with a 12 h light/dark cycle. Rats
weighing 130 ± 20 g were randomly divided into the following
groups (8 rats per group): control (C), receiving tap water
ad libitum and the standard rat chow diet; fructose (F), receiv-
ing 10% fructose (w/v) in the drinking water and the standard
rat chow diet; and fructose-(−)-epicatechin (FE), receiving 10%
fructose (w/v) in the drinking water and the standard rat chow
diet with (−)-epicatechin added to reach 20 mg per kg of body
weight per d.14 The (−)-epicatechin provided to the rats is equi-
valent to 200 mg d−1 for a 70 kg human (considering a factor
of 7 to convert rat and human doses),17 an amount that is
attainable through optimizing fruit and vegetable intake and/
or pharmacological strategies.9,18 After 8 weeks on the respect-
ive treatments, the rats were weighed and anesthetized with
ketamine (50 mg per kg of body weight) and acepromazine
(1 mg per kg of body weight). The kidneys were excised, and
the kidney cortex was immediately isolated and processed for
western blot analysis.
Western blot analysis
A portion of the renal cortex was homogenized in lysis buffer
(150 mM NaCl, 50 mM Trizma-HCl, 1% (v/v) NP-40, pH: 8.0) in
the presence of protease and phosphatase inhibitors and cen-
trifuged at 600g for 20 min. The supernatant was collected and
used as the total homogenate. Protein content was measured
by the Lowry method. The homogenates were added with
2× solution of sample buffer (62.5 mM Tris-HCl, pH: 6.8
containing 2% (w/v) SDS, 25% (w/v) glycerol, 5% (v/v)
β-mercaptoethanol, and 0.01% (w/v) bromophenol blue) and
heated at 95 °C for 2 min. Sample aliquots containing 30 μg of
protein were subjected to reducing 10% (w/v) polyacrylamide
gel electrophoresis and then transferred to polyvinylidene
difluoride membranes. Colored molecular weight standards
(GE Healthcare, Piscataway, NJ, USA) were run simultaneously.
Membranes were blotted for 2 h in 5% (w/v) nonfat milk and
incubated overnight in the presence of the corresponding
primary antibodies (1 : 1000 dilution in PBS). After subsequent
incubation for 90 min at room temperature in the presence of
the corresponding HRP-conjugated secondary antibody
(1 : 5000 dilution in PBS), the complexes were visualized by
chemiluminescence. Films were scanned, and densitometric
analysis was performed using Image J (National Institute of
Health, Bethesda, Maryland, USA). The protein bands were
normalized to the β-actin content.
Statistical analysis
Results are shown as mean ± SEM. Data were analyzed by one-
way analysis of variance (ANOVA) using StatView 5.0 (SAS
Institute, Cary, NC, USA), and Fisher’s significance difference
test was used to examine the differences between group
means. A value of p < 0.05 is considered statistically
significant.
Results and discussion
We have previously shown that (−)-epicatechin attenuated the
renal pro-inflammatory state induced by the consumption of
high-fructose diet in rats. This was associated with the attenu-
ation of NOX2 activation.8 To extend these results, in the
present study, we evaluated the effects of (−)-epicatechin on
the activation of NF-κB and on NOX expression. The obtained
results indicate that by preventing the activation of select
NOXs, (−)-epicatechin prevents the activation of NF-κB in the
kidney cortex.
In a preceding paper using the same set of rats, both high-
fructose feeding and (−)-epicatechin modified several meta-
bolic and kidney function parameters. Of importance for the
present results, kidney/body weight and serum creatinine were
not modified by the diets, but increased proteinuria (71%,
F with respect to C) associated with fructose consumption was
not observed in FE rats. These results indicate that in F rats,
there was incipient renal damage that was not enough in
extent and/or time to affect most metabolic parameters and
damage was prevented by (−)-epicatechin administration.8
TLR-4 is key in mediating NF-κB activation initiated extra-
cellularly.19 In this study, no changes were found in TLR-4
expression in the kidney cortex as a result of both high-fruc-
tose feeding and (−)-epicatechin administration (Fig. 1A).
These results suggest that most of the observed changes are
not dictated by the basal expression of TLR-4 and can possibly
be events initiated by intracellular agents such as oxidants.
The observed unmodified basal levels of TLR-4 are in contrast
with other previously reported results showing an over-
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expression of TLR-4 in the kidney of high-fructose-fed20–22 or
LPS-treated11,23 rodents. It is important to note that in LPS-
treated rats, TLR-4 was overexpressed, and (−)-epicatechin was
active to prevent such overexpression and the associated acti-
vation of NF-κB.11
NF-κB activation occurs through several regulatory events.
IKKα content was similar in the three experimental groups
(Fig. 1B). Ikkα/β phosphorylation at Ser(176/180) (p-IKKα/β)
was significantly higher in the F group compared to that in the
C and FE groups (+99% and +108%, respectively) (Fig. 1C). The
Fig. 1 Effects of dietary (−)-epicatechin on TLR-4 expression and NF-κB signaling pathway in the renal cortex of high-fructose-fed rats. TLR-4
expression (A), IKKα content (B), IKKα/β phosphorylation at Ser(176/180) (C), IκB content (D), IκBα phosphorylation at Ser(32) (E), NF-κB p65 content
(F) and NF-κB p65 phosphorylation at Ser(536) (G) determined by western blot in homogenates of the renal cortex from C: control, F: fructose, and
FE: fructose-(−)-epicatechin groups. Values are expressed as mean ± SEM; n = 8 rats per group. *p < 0.05 respect to C, #p < 0.05 respect to F.
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total content of IκBα, which is degraded during NF-κB acti-
vation, was significantly lower in the F and FE groups com-
pared to that in the C group (−37% and −31%, respectively)
(Fig. 1D). The levels of IκBα phosphorylation at Ser(32)
(p-IκBα) were significantly higher in the F group compared to
those in the C and FE groups (+113% and +80%, respectively)
(Fig. 1E). NF-κB p65 content showed no changes among the
experimental groups (Fig. 1F), but the activating phosphoryl-
ation at Ser(536) was significantly higher in the F group com-
pared to that in the C and FE groups (+41% and +22% respect-
ively) (Fig. 1G). These results indicate that (−)-epicatechin
inhibited the phosphorylation steps that control the activation
of the NF-κB pathway induced by high fructose feeding.
Similar modulatory effects of (−)-epicatechin on NF-κB acti-
vation were observed in the kidney of LPS-treated rats.11
However, in that experimental setting, IκBα protein levels were
returned to control values by (−)-epicatechin treatment,
whereas in the present experiments, (−)-epicatechin had no
effect. Such discrepancies between total IκBα protein content
and other parameters of NF-κB activation could be ascribed to
the complex turnover of IκBα associated with different kinetics
of synthesis and degradation of free and NF-κB-bound IκBα.24
Oxidant levels in cells are closely associated with NF-κB acti-
vation.25 Early reports have demonstrated that the activation of
NF-κB is associated with cellular oxidative stress26–28 and the
expressions of some NOX subunits are regulated by NF-κB.29,30
Then, a cycle involving NOX-derived oxidants and activation of
NF-κB has been proposed and supported by extensive experi-
mental evidence.31–33 However, the initiating event in this
cycle, i.e., the NF-κB pathway activation or NOX activation is
highly dependent on challenging conditions and physiological
response.25
In terms of the regulation of both, oxidant production and
NOX activities, we previously showed that the consumption of
high-fructose diets increases superoxide anion production and
the expression of NOX2 subunits p47phox and gp91phox in rat
kidneys. The administration of (−)-epicatechin counteracted
the increments in superoxide anion production and only the
expression of p47phox in the renal cortex.8 Here, we investigated
the regulation of other NOX isoforms following high fructose
consumption and (−)-epicatechin administration. NOX1
expression was similar in the three experimental groups
(Fig. 2A), but NOXO1 protein levels were 86% higher in F and
FE groups compared to that for the C group (p < 0.05)
(Fig. 2B). These results suggest greater NOX1 activity mediated
by higher NOXO1 expression in high-fructose-fed rats, an
effect that was not modified by (−)-epicatechin administration.
The absence of the effect of (−)-epicatechin on the activation
of NOX-1, especially on NOXO1, can sustain increased super-
oxide anion production that is responsible for the remaining/
Fig. 2 Effects of dietary (−)-epicatechin on NOX1, NOXO1, and NOX4 expressions in the renal cortex of high-fructose-fed rats. Protein expression
levels were measured by western blot in homogenates of the renal cortex from C: control, F: fructose; and FE: fructose-(−)-epicatechin groups.
Values are expressed as mean ± SEM; n = 8 rats per group. *p < 0.05 respect to C, #p < 0.05 respect to F.
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residual effects of the high-fructose diet on some renal para-
meters, for which alterations were not completely prevented by
(−)-epicatechin. NOX4 expressions were 61% and 46% higher
in the F group compared to that for C and FE groups (p < 0.05)
(Fig. 2C), indicating increased intracellular production of H2O2
after high fructose consumption. This effect was prevented by
(−)-epicatechin, as it was previously observed in the aorta,
liver, and adipose tissue of high-fructose-fed rats.9,14 This
regulation of NOX4 by (−)-epicatechin can be of relevance
because NOX4 activity is dictated solely by the expression of
this protein, which is a direct manner of controlling oxidant
production.
By integrating the present experiments with previous
observations,32–36 we can conclude that renal NOXs responded
differentially to a high-fructose diet and to (−)-epicatechin
administration. As summarized in Table 1, excessive fructose
in the diet was mostly associated with higher NOX activation
that followed different patterns: (i) higher expression of NOX2
activating and catalytic subunits, (ii) higher expression of the
NOX1 activating subunit, and (iii) higher expression of the
NOX4 catalytic subunit. These differences could reflect specific
activation mechanisms for each NOX isoform. (−)-Epicatechin
supplementation led to changes only in NOX2 and NOX4 that
could decrease enzymatic activation by avoiding the over-
expression of the organizer subunit of NOX2 and that of the
catalytic subunit of NOX4.
Regarding the sequence of NF-κB and NOXs activations, our
results suggest that (−)-epicatechin regulates the NF-κB signal-
ing pathway through the modulation of NOX2 and NOX4.
Then, the production of superoxide anion by NOX2 and/or the
production of H2O2 by NOX4 can define the redox regulation
of NF-κB activation probably initiated by the phosphorylation
and stabilization of IKKα. In this regard, it was demonstrated
that H2O2 favors the activating phosphorylation of the IKK
complex by inducing protein kinase D activity through Src-
mediated signaling pathways37 and mitogen-activated protein
kinase kinase kinase (MAP3K).38 Additionally, H2O2 can main-
tain high levels of activated IKK complexes through inacti-
vation of protein phosphatases by oxidative modifications.39
Finally, in agreement with the increased ratio p-IκBα/IκBα and
the lower IκBα protein expression found in the F group, it has
been postulated that H2O2 induces IκBα phosphorylation at
several tyrosine residues, favoring its proteasomal
degradation.40,41
Overall, the present results further describe the mecha-
nisms associated with the prevention of the deleterious effects
of high fructose feeding by (−)-epicatechin supplementation.
In addition, this study supports the potential use of (−)-epica-
techin-enriched foods or supplements as a nutritional tool to
help down-regulate redox-sensitive pro-inflammatory con-
ditions such as those found in diabetes, hypertension and
dyslipidemia.42,43
Abbreviations
IκBα Inhibitor of κBα
NF-κB Nuclear factor κB
NOX NADPH oxidase
NOXO1 NOX1 organizer
TLR-4 Toll-like receptor 4
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